All systems operational
Q4 2025

Evaluation of mucosal-associated invariant T cell subsets in acute myeloid leukemia

Ali A. Ahmed · Mohamed A. El-Mokhtar · Omnia H. El-Badawy · Marwa A. Sabet · Asmaa M. Zahran · Salwa S. Seif El-Din
10.4103/ejh.ejh_87_24 387 Views 0 Citations
0
Citations
387
Views
Abstract


Background
Acute myeloid leukaemia (AML) is a condition distinguished by the clonal enlargement of non-lymphoid hematopoietic progenitor cells. Mucosal-associated invariant T (MAIT) cells, were studied in hematological cancers but their potential role in AML lacks comprehensive studies so far. This study aims to determine the frequencies of various MAIT cell subsets, including MAIT cells secreting interferon-gamma (IFNγ) and granzyme B (GrB), in the peripheral blood (PB) and bone marrow of AML patients compared with the controls.


Methods
This case-control study involved 34 AML patients and 20 control patients. The frequencies of different MAIT cell subsets were evaluated using flow cytometry.


Results
A significant decrease was observed in the frequency of MAIT cells in the PB of AML patients compared with controls (P=0.001 for cluster of differentiation 8+ MAIT cells, and P < 0.001 for double negative MAIT cells). MAIT cells in AML patients exhibited heightened activation, as indicated by increased frequencies of IFNγ- and GrB-producing cells. No differences were found in the frequencies and activation of MAIT cell subsets between PB and bone marrow in AML patients. Additionally, significant differences in MAIT cell subsets were observed based on AML phenotypes and remission status.


Conclusion
Our study reveals a decreased frequency of circulating MAIT cells in AML patients, accompanied by heightened activation characterized by IFNγ, and GrB production, suggesting a potential role of MAIT cells in AML pathophysiology.

Cite this Article (APA)
Ali, A. A., Mohamed, A. E., Omnia, H. E., Marwa, A. S., Asmaa, M. Z., Salwa, S. S. E. (2025). Evaluation of mucosal-associated invariant T cell subsets in acute myeloid leukemia. Egyptian Journal of Haematology. https://doi.org/10.4103/ejh.ejh_87_24
Related Papers
Clinical significance of interleukin 10, interleukin 33, and interleukin 35 on induction chemotherap…
Aya Fergany; Khaled M. Hassanein; Asmaa M. Zahran; Muhamad R. Abdel Hameed; Ayat · 2025
5
cites
387
Is parvovirus a concern in thalassemia?
Asmaa Mahmoud; Nesrine A. Helaly; Sara A.A. Essa; Mona Hassan Fathelbab; Asmaa M · 2025
1
cites
390
Erythroferrone as iron overload biomarker in thalassemic patients: a case control study
Heba Y. Abido; Alia A. Ayad; Nouran S. Thabit; Lamyaa H. Soliman; Marwa S. Moham · 2025
1
cites
386
17p deletion and atypical flow cytometry profiles in chronic lymphocytic leukemia: correlation to cl…
Rania S. Hamza; Asmaa A.A. Alaal; Aya M.S. Hassan; Heba Y. Mohamed; Aya M.A. Ara · 2025
1
cites
390
Comparison between high-speed and low-speed centrifugation concepts for standardizing platelet-rich …
Nermeen Ahmed Eldesoukey; Nehal Diaa; Alshaymaa Ahmed Fouad; Fatma Abdel Wahab · 2026
1
cites
389
Access
View Full Text via DOI
Published in
ISSN 1110-1067
Quartile Q4
AMS Score 58
Field Medicine & Health Sciences
Publisher Egyptian Society of Haematology
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 27 Jul 2026